https://doi.org/10.1186/s12964-022-00902-7
T
Tomoki Inagaki
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
49
Papers
754
Citations
15
h-index
20
i10-index
Tomoki Inagaki is an academic researcher from University of California, Davis. The author has contributed to research in topics: Viral-associated cancers and disorders & Cytomegalovirus and herpesvirus research & Herpesvirus Infections and Treatments. The author has an h-index of 15, co-authored 42 publications.
ORCID: 0009-0007-2332-9895Papers by this author
worksEpstein–Barr virus tegument protein BGLF2 in exosomes released from virus-producing cells facilitates de novo infection
2022 · Cell Communication and Signaling · 17 citations
Kaposi’s sarcoma-associated herpesvirus (KSHV) LANA prevents KSHV episomes from degradation
2024 · Journal of Virology · 15 citations
https://doi.org/10.1128/jvi.01268-23
A LANA peptide inhibits tumor growth by inducing CHD4 protein cleavage and triggers cell death
2024 · Cell chemical biology · 4 citations
https://doi.org/10.1016/j.chembiol.2024.10.003
Design, development, and evaluation of gene therapeutics specific to KSHV-associated diseases
2025 · Molecular Therapy Oncology · 4 citations
https://doi.org/10.1016/j.omton.2025.201050
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat